value-added medicines

Sales & Marketing

James Burt, CEO of Pharmanovia, is a seasoned leader focused on driving innovation in the value-added medicines (VAMs) space.

News

The FDA has named Dexcom as the first company to take part in its TEMPO pilot, which aims to bring digital health tech to patients more quickly.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.